{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:40:10Z","timestamp":1792147210481,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ando.2013.02.008","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T04:18:18Z","timestamp":1366172298000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: Which clinical arguments?"],"prefix":"10.1016","volume":"74","author":[{"given":"Olivier","family":"Rosmorduc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2013.02.008_bib0005","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/archinte.167.18.1983","article-title":"Epidemiology of hepatocellular carcinoma in Hispanics in the United States","volume":"167","author":"El-Serag","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ando.2013.02.008_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0015","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ando.2013.02.008_bib0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ando.2013.02.008_bib0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/jhep.2003.50320","article-title":"Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis\u00a0C","volume":"38","author":"Hui","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/jhep.2000.17894","article-title":"Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study","volume":"32","author":"Poonawala","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0035","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/jhep.2002.33324","article-title":"Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis","volume":"35","author":"Ratziu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0040","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0045","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ando.2013.02.008_bib0050","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2008.07.024","article-title":"A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma","volume":"49","author":"de Lima","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ando.2013.02.008_bib0055","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2007.02.006","article-title":"Non-alcoholic steatohepatitis and cancer","volume":"11","author":"Bugianesi","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ando.2013.02.008_bib0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","article-title":"The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21years","volume":"11","author":"Powell","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma","volume":"123","author":"Bugianesi","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ando.2013.02.008_bib0075","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.1840360609","article-title":"NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marrero","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0080","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jhep.2004.05.008","article-title":"Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma","volume":"41","author":"Bullock","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.ando.2013.02.008_bib0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1440-1827.2001.01174.x","article-title":"Hepatocellular carcinoma arising in non-alcoholic steatohepatitis","volume":"51","author":"Zen","year":"2001","journal-title":"Pathol Int"},{"issue":"Suppl.\u00a019","key":"10.1016\/j.ando.2013.02.008_bib0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00535-008-2262-x","article-title":"Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"44","author":"Hashimoto","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ando.2013.02.008_bib0095","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","article-title":"Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis","volume":"49","author":"Paradis","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0100","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis","volume":"128","author":"Ertle","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ando.2013.02.008_bib0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.34738","article-title":"Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?","volume":"36","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0110","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.3748\/wjg.v16.i46.5801","article-title":"Leptin in hepatocellular carcinoma","volume":"16","author":"Wang","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ando.2013.02.008_bib0115","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/gast.2002.32995","article-title":"Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat","volume":"122","author":"Ikejima","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ando.2013.02.008_bib0120","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2010.04.035","article-title":"Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis","volume":"53","author":"Nkontchou","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.ando.2013.02.008_bib0125","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2013.02.008_bib0130","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6603932","article-title":"Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies","volume":"97","author":"Larsson","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ando.2013.02.008_bib0135","first-page":"13","article-title":"A prospective study of obesity and cancer risk (Sweden)","volume":"12","author":"Wolk","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ando.2013.02.008_bib0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/annonc\/mdn565","article-title":"The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma","volume":"20","author":"Polesel","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ando.2013.02.008_bib0145","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0959-8049(94)90254-2","article-title":"Obesity and cancer risk: a Danish record-linkage study","volume":"30A","author":"Moller","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ando.2013.02.008_bib0150","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1200\/JCO.2005.11.726","article-title":"Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study","volume":"23","author":"Oh","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2013.02.008_bib0155","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1200\/JCO.2006.07.0243","article-title":"Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study","volume":"24","author":"Park","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2013.02.008_bib0160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/jhep.2002.33713","article-title":"Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?","volume":"36","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0165","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gut.2008.164053","article-title":"Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH","volume":"58","author":"Ohki","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.ando.2013.02.008_bib0170","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/jnci\/92.13.1096","article-title":"Role of diabetes mellitus in the etiology of hepatocellular carcinoma","volume":"92","author":"Lagiou","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ando.2013.02.008_bib0175","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ando.2013.02.008_bib0180","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","article-title":"Fasting serum glucose level and cancer risk in Korean men and women","volume":"293","author":"Jee","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2013.02.008_bib0185","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1478-3231.2010.02223.x","article-title":"Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease","volume":"30","author":"Donadon","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.ando.2013.02.008_bib0190","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1053\/j.gastro.2009.01.053","article-title":"Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes","volume":"136","author":"El-Serag","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ando.2013.02.008_bib0195","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","article-title":"The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence","volume":"4","author":"El-Serag","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ando.2013.02.008_bib0200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.23641","article-title":"Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications","volume":"52","author":"Chen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0205","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2002.36780","article-title":"Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus","volume":"36","author":"Hassan","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0210","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.11427","article-title":"Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection","volume":"97","author":"Ohata","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2013.02.008_bib0215","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1002\/cncr.22701","article-title":"Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis","volume":"109","author":"Pekow","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2013.02.008_bib0220","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2008.03.073","article-title":"Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B\/C infection: a follow-up study in Taiwan","volume":"135","author":"Chen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ando.2013.02.008_bib0225","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1478-3231.2009.02043.x","article-title":"Diabetes pattern on the 75g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus","volume":"29","author":"Konishi","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.ando.2013.02.008_bib0230","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1200\/JCO.2008.16.1075","article-title":"Body-mass index and progression of hepatitis B: a population-based cohort study in men","volume":"26","author":"Yu","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2013.02.008_bib0235","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jhep.2008.09.011","article-title":"Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis","volume":"50","author":"Sorrentino","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.ando.2013.02.008_bib0240","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1002\/cncr.24687","article-title":"Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link","volume":"115","author":"Siegel","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2013.02.008_bib0245","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ando.2013.02.008_bib0250","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.3748\/wjg.v16.i29.3603","article-title":"Non-viral causes of hepatocellular carcinoma","volume":"16","author":"Blonski","year":"2010","journal-title":"World J Gastroenterol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426613000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426613000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:45:25Z","timestamp":1757717125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426613000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0003426613000267"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2013.02.008","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: Which clinical arguments?","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2013.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}